NIMBC treatment, cryo spray for hollow & humid organs

Vessi Medical is at the forefront of developing a unique cryo spray technology specifically designed for treating urological tissues in hollow and humid organs. This innovative approach offers a minimally invasive alternative to traditional surgical procedures, which are often costly and associated with significant complications. The Vessi system includes a standalone console and a disposable device that allows for transurethral insertion into the bladder, facilitating effective treatment while minimizing risks. The cryotherapy technique employed by Vessi Medical is non-contact, which enhances its safety profile and effectiveness in targeting both the tissue and surrounding areas.

The Vessi system is designed to be user-friendly and can be performed in an office setting without the need for general anesthesia in some cases. This flexibility not only reduces the overall healthcare costs but also improves patient outcomes by decreasing the incidence of complications such as bleeding and perforations. The technology also incorporates advanced visualization capabilities, allowing for clear imaging within mixed liquid and gas environments during the treatment process. Overall, Vessi Medical's cryo spray represents a significant advancement in the field of urology, addressing the limitations of current treatment options and enhancing the quality of care for patients.

Israel

Vessi Medical is developing an innovative, IP protected cryo spray for hollow & humid organs, a new approach in the treatment of Non Muscle Invasive Bladder Cancer.

Vessi Medical

Company Details